Analytical Chemistry Laboratory, CIRM, University of Liège, Avenue de l'Hôpital 1, B36, B-4000 Liège, Belgium.
Anal Chim Acta. 2011 Oct 31;705(1-2):193-206. doi: 10.1016/j.aca.2011.05.028. Epub 2011 May 23.
Methods validation is mandatory in order to assess the fitness of purpose of the developed analytical method. Of core importance at the end of the validation is the evaluation of the reliability of the individual results that will be generated during the routine application of the method. Regulatory guidelines provide a general framework to assess the validity of a method, but none address the issue of results reliability. In this study, a Bayesian approach is proposed to address this concern. Results reliability is defined here as "the probability (π) of an analytical method to provide analytical results (X) within predefined acceptance limits (±λ) around their reference or conventional true concentration values (μ(T)) over a defined concentration range and under given environmental and operating conditions." By providing the minimum reliability probability (π(min)) needed for the subsequent routine application of the method, as well as specifications or acceptance limits (±λ), the proposed Bayesian approach provides the effective probability of obtaining reliable future analytical results over the whole concentration range investigated. This is summarised in a single graph: the reliability profile. This Bayesian reliability profile is also compared to two frequentist approaches, the first one derived from the work of Dewé et al. [W. Dewé, B. Govaerts, B. Boulanger, E. Rozet, P. Chiap, Ph. Hubert, Chemometr. Intell. Lab. Syst. 85 (2007) 262-268] and the second proposed by Govaerts et al. [B. Govaerts, W. Dewé, M. Maumy, B. Boulanger, Qual. Reliab. Eng. Int. 24 (2008) 667-680]. Furthermore, to illustrate the applicability of the Bayesian reliability profile, this approach is also applied here to a bioanalytical method dedicated to the determination of ketoglutaric acid (KG) and hydroxymethylfurfural (HMF) in human plasma by SPE-HPLC-UV.
方法验证对于评估所开发分析方法的适用性至关重要。验证工作的核心是评估在常规应用方法过程中产生的各个结果的可靠性。法规指南提供了评估方法有效性的总体框架,但没有一个涉及结果可靠性问题。在本研究中,提出了一种贝叶斯方法来解决这个问题。这里将结果可靠性定义为“在给定的环境和操作条件下,分析方法在预定浓度范围内,围绕其参考或常规真实浓度值(μ(T)),在预设接受限(±λ)内提供分析结果(X)的概率(π)”。通过提供方法后续常规应用所需的最小可靠性概率(π(min)),以及规范或接受限(±λ),所提出的贝叶斯方法提供了在整个研究浓度范围内获得可靠未来分析结果的有效概率。这在一张图中进行了总结:可靠性概况。该贝叶斯可靠性概况还与两种频率论方法进行了比较,第一种方法源自 Dewé 等人的工作[W. Dewé, B. Govaerts, B. Boulanger, E. Rozet, P. Chiap, Ph. Hubert, Chemometr. Intell. Lab. Syst. 85 (2007) 262-268],第二种方法由 Govaerts 等人提出[B. Govaerts, W. Dewé, M. Maumy, B. Boulanger, Qual. Reliab. Eng. Int. 24 (2008) 667-680]。此外,为了说明贝叶斯可靠性概况的适用性,本研究还将该方法应用于一种生物分析方法,用于通过 SPE-HPLC-UV 测定人血浆中的酮戊二酸(KG)和羟甲基糠醛(HMF)。